Innovent's mazdutide outperforms semaglutide in diabetes trial
Tweet Send to a Friend
Innovent Biologics Inc. (HKEX: 01801) reported that its drug mazdutide demonstrated superior effectiveness compared to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


